España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ingevity
NGVT
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$46.01
-0.73
-1.56%
At close: -
$46.01
0.00
0.00%
After Hours: Feb 21, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings were released on Tue Feb 18th, after the market close
The most recent conference call was at 10:00 AM, 4 days ago
Click to view past webcast
Ingevity (NGVT) Forecast
News
Earnings
Ingevity (NGVT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ingevity (NYSE:NGVT) Stock
Ingevity Stock (NYSE: NGVT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 20, 2025
BMO Capital Maintains Market Perform on Ingev...
Benzinga Newsdesk
Tuesday, February 18, 2025
Ingevity Expects FY25 Sales Of $1.3B - $1.4B,...
Benzinga Newsdesk
Ingevity Q4 2024 Adj EPS $0.95 Beats $0.31 Es...
Benzinga Newsdesk
Earnings Scheduled For February 18, 2025
Benzinga Insights
Friday, January 17, 2025
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Anthony Noto
Thursday, January 16, 2025
Ingevity shares are trading higher after the ...
Benzinga Newsdesk
Ingevity Explores Strategic Options For Performance Chemicals Segment To Strengthen Portfolio, Projects FY24 Revenue At $1.40 Billion
Akanksha Bakshi
Ingevity Announced Preliminary 2024 Sales Of ...
Benzinga Newsdesk
Ingevity Announced That It Is Exploring Strat...
Benzinga Newsdesk
Thursday, October 31, 2024
In-Depth Examination Of 4 Analyst Recommendations For Ingevity
Benzinga Insights
BMO Capital Maintains Market Perform on Ingev...
Benzinga Newsdesk
Wednesday, October 30, 2024
Ingevity shares are trading higher after the ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Ingevity Affirms FY Guidance Of Sales $1.40B-...
Benzinga Newsdesk
Ingevity Q3 2024 Adj EPS $1.10 Beats $0.90 Es...
Benzinga Newsdesk
Monday, October 28, 2024
A Look Ahead: Ingevity's Earnings Forecast
Benzinga Insights
Thursday, October 03, 2024
Nasdaq Moves Lower; Levi Strauss Shares Slide
Avi Kapoor
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
Avi Kapoor
Ingevity shares are trading lower. The compan...
Benzinga Newsdesk
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
Ingevity Says John Fortson Has Departed As Pr...
Benzinga Newsdesk
Monday, September 30, 2024
BMO Capital Maintains Market Perform on Ingev...
Benzinga Newsdesk
Wednesday, September 11, 2024
Ingevity to Unveil Sustainable Capa L Polyols...
Benzinga Newsdesk
Tuesday, August 06, 2024
Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month
Avi Kapoor
Monday, August 05, 2024
Ingevity shares are trading lower amid contin...
Benzinga Newsdesk
BMO Capital Maintains Market Perform on Ingev...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Ingevit...
Benzinga Newsdesk
Thursday, August 01, 2024
Unveiling 4 Analyst Insights On Ingevity
Benzinga Insights
Oppenheimer Maintains Outperform on Ingevity,...
Benzinga Newsdesk
Wednesday, July 31, 2024
Ingevity Announces Additional Steps To Advanc...
Benzinga Newsdesk
Ingevity Revises FY24 Revenue To $1.40B-$1.50...
Benzinga Newsdesk
Ingevity Q2 Adj $1.01 Misses $1.05 Estimate, ...
Benzinga Newsdesk
Thursday, July 11, 2024
Assessing Ingevity: Insights From 5 Financial Analysts
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Ingevit...
Benzinga Newsdesk
Tuesday, July 09, 2024
Ingevity And Ultrapolymers Group Partner For ...
Benzinga Newsdesk
Monday, July 08, 2024
Ingevity Says On July 1, Co, Georgia Pacific ...
Benzinga Newsdesk
Wednesday, May 08, 2024
BMO Capital Maintains Market Perform on Ingev...
Benzinga Newsdesk
Tuesday, May 07, 2024
Ingevity Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
Loop Capital Maintains Hold on Ingevity, Rais...
Benzinga Newsdesk
Thursday, May 02, 2024
Oppenheimer Maintains Outperform on Ingevity,...
Benzinga Newsdesk
Wednesday, May 01, 2024
Ingevity Reiterates FY24 Sales $1.40B-$1.55B ...
Benzinga Newsdesk
Ingevity Q1 2024 Adj EPS $0.52 Beats $0.32 Es...
Benzinga Newsdesk
Monday, April 22, 2024
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Ingevity shares are trading higher after Jeff...
Benzinga Newsdesk
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Jefferies Upgrades Ingevity to Buy, Raises Pr...
Benzinga Newsdesk
Wednesday, February 21, 2024
Ingevity Sees FY24 Sales $1.4B-$1.55B Vs $1.4...
Benzinga Newsdesk
Ingevity Q4 2023 Adj EPS $0.21 Beats $(0.19) ...
Benzinga Newsdesk
Recap: Ingevity Q4 Earnings
Benzinga Insights
Earnings Scheduled For February 21, 2024
Benzinga Insights
Tuesday, February 20, 2024
Ingevity's Earnings Outlook
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
